Insilico collaborates with Pfizer on novel data and AI system for target discovery

The last collaboration of the famous Insilico Medicine Hong Kong company is the Pfizer laboratories. After a very busy year 2019 with publications in Nature Biotechnology and more than 35 millions dollars rond, the company increase partnership in the pharmaceutical domain. His patented technology is focused on the use of AI algorithms to find best combinations between drugs and molecular targets. This way to find new drugs could be the game changer in the future…

"Insilico collaborates with Pfizer on novel data and AI system for target discovery"

The emerging world of digital therapeutics

In this article, we discover several examples of “digital therapeutics”. Even if this new kind of drugs is not so new, first were used 10 years ago, we have seen a lot of new solutions in the previous 2 or 3 years. More and more clinical trials are ongoing and most of the biggest pharmaceuticals industries work on it. Authors describe the history of this domain and explain in particular links with more classical drugs…

"The emerging world of digital therapeutics"